Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne
0834.829.411 · rovalta.com · 28/09/2026
Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne
Company — Normal situation.
Financial year 2022 · Closed on 31/12/2022
Overview
Identity
Source · BCE/KBOEtudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0834.829.411
- Legal form
- Economic interest grouping with a registered office in Belgium
- Latest accounts
- 31/12/2022
Financials
Source · NBB, 12 filingsTrend over 12 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -324,2 € | -178% | 415,1 € | -97.2% | 14,6 k € | -33.7% | 22 k € | -41.9% | 37,9 k € |
| EBITDA | -324,2 € | -178% | 415,1 € | -97.2% | 14,6 k € | -33.7% | 22 k € | -41.9% | 37,9 k € |
| Operating result | -324,2 € | -178% | 415,1 € | -97.2% | 14,6 k € | -33.7% | 22 k € | -41.9% | 37,9 k € |
| Net result | -357 € | -199% | 360,1 € | -97.5% | 14,6 k € | -33.8% | 22 k € | -41.9% | 37,9 k € |
| Balance sheet | |||||||||
| Total assets | 6,3 k € | -19.4% | 7,9 k € | +5.5% | 7,4 k € | -76.2% | 31,3 k € | +126% | 13,9 k € |
| Cash | 6,1 k € | -0.1% | 6,1 k € | +9.3% | 5,6 k € | -79.6% | 27,6 k € | +194% | 9,4 k € |
| Debts | 6,3 k € | -19.4% | 7,9 k € | +5.5% | 7,4 k € | -76.2% | 31,3 k € | +126% | 13,9 k € |
Board of directors
Source · NBB, accounts to 31/12/20221 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
| Director10/06/2021 → 04/06/2026 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
| Manager |
Financials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 | 01/01/2017 |
| Closing of the financial year | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 | 31/12/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 14/07/2023 | 20/07/2022 | 30/09/2021 | 05/10/2020 | 30/08/2019 | 14/06/2018 |
| General meeting | 22/06/2023 | 09/06/2022 | 29/09/2021 | 24/09/2020 | 06/06/2019 | 07/06/2018 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2022 | 22/06/2023 | 14/07/2023 | French | |
| Micro model | 31/12/2021 | 09/06/2022 | 20/07/2022 | French | |
| Micro model | 31/12/2020 | 29/09/2021 | 30/09/2021 | French | |
| Micro model | 31/12/2019 | 24/09/2020 | 05/10/2020 | French | |
| Micro model | 31/12/2018 | 06/06/2019 | 30/08/2019 | French | |
| Micro model | 31/12/2017 | 07/06/2018 | 14/06/2018 | French | |
| Micro model | 31/12/2016 | 01/06/2017 | 22/08/2017 | French | |
| Abridged model | 31/12/2015 | 02/06/2016 | 23/08/2016 | French | |
| Abridged model | 31/12/2014 | 04/06/2015 | 07/07/2015 | French | |
| Abridged model | 31/12/2013 | 05/06/2014 | 23/09/2014 | French | |
| Abridged model | 31/12/2012 | 06/06/2013 | 24/06/2013 | French | |
| Abridged model | 31/12/2011 | 07/06/2012 | 02/07/2012 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20221 active · 1 ended
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
| Director10/06/2021 → 04/06/2026 |
Ended mandates
| Director | Mandates in this company | Period |
|---|---|---|
| Manager |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution31/08/2023Dissolution + clôture de liquidation
- Mandates04/03/2022SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Mandates31/12/2020DEMISSIONS, NOMINATIONS
- Mandates19/07/2017DEMISSIONS, NOMINATIONS
- Mandates16/09/2016DEMISSIONS, NOMINATIONS
- Mandates18/07/2012DEMISSIONS, NOMINATIONS
- Other06/04/2011RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| rue des Déportés 137, 6700 Arlon | accounts 2021 → 2022 | Accounts 2022 · 2023-00234924 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne | accounts 2022 | Accounts 2022 · 2023-00234924 |
| Etudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne. En abrégé, Etudes cliniques-CSL-MI | accounts 2021 | Accounts 2021 · 2022-20202774 |
Events
- 2022Annual accounts 2022-357 €↓
- 2022Name changeEtudes cliniques-Cliniques du Sud-Luxembourg-Médecine Interne
- 2021Annual accounts 2021360,1 €↓
- 2020Annual accounts 202014,6 k €↓
- 2019Annual accounts 201922 k €↓
- 2018Annual accounts 201837,9 k €↓
- 2017Annual accounts 201744,1 k €↓
- 2016Annual accounts 201665,6 k €↓
- 2015Annual accounts 201571,5 k €↑
- 2014Annual accounts 201470,4 k €↑
- 2013Annual accounts 201324,1 k €↑
- 2012Annual accounts 201215 k €↓
- 2011Annual accounts 201161,8 k €